Group One Trading
WVE icon

Group One Trading’s Wave Life Sciences WVE Stock Holding History

Group One Trading’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.8K Sell
9,600
-72,100
-88% -$478K ﹤0.01% 5326
2026
Q1 		$592K Buy
81,700
+56,900
+229% +$741K ﹤0.01% 3188
2025
Q4 		$422K Buy
24,800
+1,800
+8% +$18.3K ﹤0.01% 3692
2025
Q3 		$168K Buy
23,000
+14,700
+177% +$119K ﹤0.01% 4857
2025
Q2 		$54K Sell
8,300
-500
-6% -$3.3K ﹤0.01% 5519
2025
Q1 		$71.1K Sell
8,800
-55,100
-86% -$603K ﹤0.01% 4880
2024
Q4 		$790K Buy
63,900
+58,100
+1,002% +$776K ﹤0.01% 2778
2024
Q3 		$47.6K Buy
+5,800
New +$34.7K ﹤0.01% 4686
2024
Q2 		– Sell
-100
Closed -$617 – 7589
2024
Q1 		$617 Sell
100
-9,900
-99% -$49.6K ﹤0.01% 6708
2023
Q4 		$50.5K Buy
10,000
+4,800
+92% +$25.7K ﹤0.01% 5048
2023
Q3 		$29.9K Sell
5,200
-1,500
-22% -$6.85K ﹤0.01% 5556
2023
Q2 		$24.4K Sell
6,700
-2,000
-23% -$8.08K ﹤0.01% 5838
2023
Q1 		$37.7K Sell
8,700
-400
-4% -$1.83K ﹤0.01% 5063
2022
Q4 		$63.7K Buy
9,100
+8,700
+2,175% +$40.1K ﹤0.01% 4811
2022
Q3 		$1K Hold
400
– – ﹤0.01% 7394
2022
Q2 		$1K Sell
400
-10,900
-96% -$21K ﹤0.01% 7641
2022
Q1 		$23K Buy
11,300
+8,000
+242% +$19.6K ﹤0.01% 6675
2021
Q4 		$10K Sell
3,300
-1,200
-27% -$4.98K ﹤0.01% 7362
2021
Q3 		$22K Sell
4,500
-22,900
-84% -$139K ﹤0.01% 7125
2021
Q2 		$182K Sell
27,400
-24,200
-47% -$158K ﹤0.01% 5336
2021
Q1 		$289K Buy
51,600
+33,400
+184% +$321K ﹤0.01% 4619
2020
Q4 		$143K Sell
18,200
-72,600
-80% -$609K ﹤0.01% 4314
2020
Q3 		$771K Buy
90,800
+73,400
+422% +$805K ﹤0.01% 2435
2020
Q2 		$181K Sell
17,400
-14,000
-45% -$132K ﹤0.01% 3461
2020
Q1 		$294K Sell
31,400
-84,800
-73% -$722K ﹤0.01% 2443
2019
Q4 		$931K Buy
116,200
+110,700
+2,013% +$2.71M 0.01% 1954
2019
Q3 		$113K Buy
5,500
+2,000
+57% +$45.9K ﹤0.01% 3476
2019
Q2 		$91K Buy
+3,500
New +$98.1K ﹤0.01% 3427

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Group One Trading's WVE Position: Q2 2026 in Review

Group One Trading sold out of Wave Life Sciences (WVE) in Q2 2026, closing a stake of 6,260 shares — an estimated $41.5K sold.

Group One Trading first reported a position in WVE in Q2 2019 and held it in 22 quarters. The position peaked at $1.16M in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Group One Trading reported no remaining Wave Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 6,260 Wave Life Sciences shares in Q2 2026, an estimated $41.5K.
  • Group One Trading first reported a position in Wave Life Sciences in Q2 2019 and held it in 22 quarters.
  • Group One Trading's Wave Life Sciences position peaked at $1.16M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.